Drugs / Radion™-Pdt
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 2 | NCT03279744 | Sep 2017 → Sep 2019 | erythroplakia | Pharma Power Biotec Co., Ltd. | Completed | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Radion-Pdt | “A Prospective, Single-Arm, Open-Label, Phase II. Study to Evaluate the Efficacy and Safety of Photodynamic Therapy Using Radion™-Pdt in Patients With Oral Precancerous Lesion...” NCT03279744 ↗ |
| Route | Topical | “The Radion™-pdt will be applied topically to the lesion.” NCT03279744 ↗ |